Binding protein as biosensors

• US 7,316,909 B2
• Filed: 06/19/2006
• Issued: 01/08/2008
• Est. Priority Date: 01/04/2002
• Status: Expired due to Fees

• Current Assignee: Becton, Dickinson & Co
• Original Assignee: Becton, Dickinson & Co
• Inventors: Hsieh, Helen V., Pfieffer, Zachary A., Pitner, J. Bruce, Gestwicki, Jason E.
• Primary Examiner(s): Tsang; Cecilia J.
• Assistant Examiner(s): Teller; Roy
• Application Number:
  US11/424,892
• Publication Number:
  US 20060216752A1
• Time in Patent Office: 568 Days
• Field of Search: None
• US Class Current: 435/7.1
• CPC Class Codes: G01N 33/54373 involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
• CPC Class Codes: G01N 33/66 involving blood sugars, e.g. galactose

Abstract

The invention is directed to compositions of mutated binding proteins containing thiol groups for coupling to sensor surfaces, analyte biosensor devices derived there from, and methods of their use as analyte biosensors both in vitro and in vivo.

Claims

1. A method for detecting the concentration of an analyte in a sample, the method comprising:

a. exposing the sample to a biosensor comprising (i) at least one mutated glucose/galactose binding protein having at least one substituted or added cysteine group, and (ii) at least one sensor surface wherein said mutated binding protein is attached to said surface through said at least one cysteine group; and

b. detecting a signal from the biosensor upon binding of the analyte to said mutated binding protein,

wherein the signal is indicative of the concentration of the analyte in the sample.

2. The method of claim 1, wherein the signal is reversible.

3. The method of claim 2, wherein the signal results from a change in the refractive index of the surface.

4. The method of claim 3, wherein the analyte is glucose or galactose.

5. The method of claim 4, wherein said mutated binding protein comprises at least one amino acid substitution.

6. The method of claim 5, wherein said mutated binding protein comprises at least one amino acid substitution selected from the group consisting of a cysteine at position 11, a cysteine at position 14, a cysteine at position 19, a cysteine at position 43, a cysteine at position 74, a cysteine at position 107, a cysteine at position 110, a cysteine at position 112, a cysteine at position 113, a cysteine at position 149, a cysteine at position 213, a cysteine at position 216, a cysteine at position 238, a cysteine at position 287, and a cysteine at position 292.

7. The method of claim 6, wherein said mutated binding protein comprises at least one histidine tag.

8. The method of claim 7, wherein said mutated binding protein comprises a cysteine present at position 213.

9. The method of claim 7, wherein said mutated binding protein comprises a cysteine present at position 149.

10. The method of claim 5, wherein said mutated binding protein comprises at least two amino acid substitutions selected from the group consisting of:

a cysteine at position 112 and a serine at position 238;

a cysteine at position 149 and a serine at position 238;

a cysteine at position 152 and a cysteine at position 182;

a cysteine at position 152 and a serine at position 213;

a cysteine at position 213 and a cysteine at position 238;

a cysteine at position 149 and an arginine at position 213;

a cysteine at position 149 and a serine at position 213 and a serine at position 238; and

a cysteine at position 149 and an arginine at position 213 and a serine at position 238, coupled to said sensor surface.

11. The method of claim 10, wherein said mutated binding protein further comprises a histidine tag.

12. The method of claim 2, wherein said at least one sensor surface comprises a metal layer having conduction band electrons capable of resonating with light, thereby providing a detectable signal.

13. The method of claim 12 wherein said metal layer comprises silver or gold.

14. The method of claim 13, wherein the detectable signal results from light scattering.

15. The method of claim 14, wherein the analyte is glucose or galactose.

16. The method of claim 15, wherein said mutated binding protein comprises at least one amino acid substitution.

17. The method of claim 16, wherein said mutated binding protein comprises at least one amino acid substitution selected from the group consisting of:

a cysteine at position 11, a cysteine at position 14, a cysteine at position 19, a cysteine at position 43, a cysteine at position 74, a cysteine at position 107, a cysteine at position 110, a cysteine at position 112, a cysteine at position 113, a cysteine at position 149, a cysteine at position 213, a cysteine at position 216, a cysteine at position 238, a cysteine at position 287, and a cysteine at position 292.

18. The method of claim 17, wherein said mutated binding protein comprises at least one histidine tag.

19. The method of claim 18, wherein said mutated binding protein comprises a cysteine present at position 213.

20. The method of claim 18, wherein said mutated binding protein comprises a cysteine present at position 149.

21. The method of claim 16, wherein said mutated binding protein comprises at least two amino acid substitutions selected from the group consisting of:

a cysteine at position 112 and a serine at position 238;

a cysteine at position 149 and a serine at position 238;

a cysteine at position 152 and a cysteine at position 182;

a cysteine at position 152 and a serine at position 213;

a cysteine at position 213 and a cysteine at position 238;

a cysteine at position 149 and an arginine at position 213;

a cysteine at position 149 and a serine at position 213 and a serine at position 238; and

a cysteine at position 149 and an arginine at position 213 and a serine at position 238, coupled to said sensor surface.

22. The method of claim 21, wherein said mutated binding protein further comprises a histidine tag.